IOL CHEMICALS AND PHARMACEUTICALS
|
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
INCOME : | |||
Gross Sales | ₹2,217 Cr | ₹2,184 Cr | ₹2,184 Cr |
Sales | ₹2,202 Cr | ₹2,168 Cr | ₹2,168 Cr |
Job Work/ Contract Receipts | - | - | - |
Processing Charges / Service Income | - | - | - |
Revenue from property development | - | - | - |
Other Operational Income | ₹15 Cr | ₹16 Cr | ₹16 Cr |
Less: Excise Duty | - | - | - |
Net Sales | ₹2,217 Cr | ₹2,184 Cr | ₹2,184 Cr |
EXPENDITURE : | |||
Increase/Decrease in Stock | ₹-18 Cr | ₹-52 Cr | ₹-52 Cr |
Raw Material Consumed | ₹1,565 Cr | ₹1,623 Cr | ₹1,623 Cr |
Opening Raw Materials | ₹243 Cr | ₹182 Cr | ₹182 Cr |
Purchases Raw Materials | ₹1,427 Cr | ₹1,640 Cr | ₹1,640 Cr |
Closing Raw Materials | ₹134 Cr | ₹243 Cr | ₹243 Cr |
Other Direct Purchases / Brought in cost | ₹29 Cr | ₹44 Cr | ₹44 Cr |
Other raw material cost | - | - | - |
Power & Fuel Cost | ₹132 Cr | ₹78 Cr | ₹78 Cr |
Electricity & Power | ₹132 Cr | ₹78 Cr | ₹78 Cr |
Oil, Fuel & Natural gas | - | - | - |
Coals etc | - | - | - |
Other power & fuel | - | - | - |
Employee Cost | ₹168 Cr | ₹141 Cr | ₹141 Cr |
Salaries, Wages & Bonus | ₹150 Cr | ₹125 Cr | ₹125 Cr |
Contributions to EPF & Pension Funds | ₹11 Cr | ₹9.77 Cr | ₹9.77 Cr |
Workmen and Staff Welfare Expenses | ₹6.82 Cr | ₹6.25 Cr | ₹6.25 Cr |
Other Employees Cost | - | - | - |
Other Manufacturing Expenses | ₹43 Cr | ₹37 Cr | ₹37 Cr |
Sub-contracted / Out sourced services | - | - | - |
Processing Charges | - | - | - |
Repairs and Maintenance | ₹13 Cr | ₹11 Cr | ₹11 Cr |
Packing Material Consumed | - | - | - |
Other Mfg Exp | ₹30 Cr | ₹26 Cr | ₹26 Cr |
General and Administration Expenses | ₹6.54 Cr | ₹5.12 Cr | ₹5.12 Cr |
Rent , Rates & Taxes | ₹0.71 Cr | ₹0.62 Cr | ₹0.62 Cr |
Insurance | ₹5.54 Cr | ₹4.25 Cr | ₹4.25 Cr |
Printing and stationery | - | - | - |
Professional and legal fees | - | - | - |
Traveling and conveyance | - | - | - |
Other Administration | ₹0.29 Cr | ₹0.25 Cr | ₹0.25 Cr |
Selling and Distribution Expenses | ₹62 Cr | ₹67 Cr | ₹67 Cr |
Advertisement & Sales Promotion | - | - | - |
Sales Commissions & Incentives | - | - | - |
Freight and Forwarding | ₹50 Cr | ₹57 Cr | ₹57 Cr |
Handling and Clearing Charges | - | - | - |
Other Selling Expenses | ₹12 Cr | ₹9.50 Cr | ₹9.50 Cr |
Miscellaneous Expenses | ₹33 Cr | ₹27 Cr | ₹27 Cr |
Bad debts /advances written off | - | - | - |
Provision for doubtful debts | ₹0.02 Cr | ₹1.27 Cr | ₹1.27 Cr |
Losson disposal of fixed assets(net) | ₹0.59 Cr | ₹1.09 Cr | ₹1.09 Cr |
Losson foreign exchange fluctuations | - | - | - |
Losson sale of non-trade current investments | - | - | - |
Other Miscellaneous Expenses | ₹32 Cr | ₹25 Cr | ₹25 Cr |
Less: Expenses Capitalised | - | - | - |
Total Expenditure | ₹1,991 Cr | ₹1,926 Cr | ₹1,926 Cr |
Operating Profit (Excl OI) | ₹226 Cr | ₹258 Cr | ₹258 Cr |
Other Income | ₹26 Cr | ₹32 Cr | ₹32 Cr |
Interest Received | ₹17 Cr | ₹18 Cr | ₹18 Cr |
Dividend Received | - | - | - |
Profit on sale of Fixed Assets | - | - | - |
Profits on sale of Investments | - | - | - |
Provision Written Back | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr |
Foreign Exchange Gains | ₹7.06 Cr | ₹10 Cr | ₹10 Cr |
Others | ₹1.72 Cr | ₹3.46 Cr | ₹3.46 Cr |
Operating Profit | ₹251 Cr | ₹290 Cr | ₹290 Cr |
Interest | ₹16 Cr | ₹8.29 Cr | ₹8.29 Cr |
InterestonDebenture / Bonds | - | - | - |
Interest on Term Loan | ₹11 Cr | ₹2.25 Cr | ₹2.25 Cr |
Intereston Fixed deposits | - | - | - |
Bank Charges etc | ₹5.78 Cr | ₹5.86 Cr | ₹5.86 Cr |
Other Interest | ₹0.07 Cr | ₹0.18 Cr | ₹0.18 Cr |
PBDT | ₹235 Cr | ₹282 Cr | ₹282 Cr |
Depreciation | ₹46 Cr | ₹43 Cr | ₹43 Cr |
Profit Before Taxation & Exceptional Items | ₹189 Cr | ₹239 Cr | ₹239 Cr |
Exceptional Income / Expenses | - | ₹-14 Cr | ₹-14 Cr |
Profit Before Tax | ₹189 Cr | ₹225 Cr | ₹225 Cr |
Provision for Tax | ₹50 Cr | ₹57 Cr | ₹57 Cr |
Current Income Tax | ₹45 Cr | ₹57 Cr | ₹57 Cr |
Deferred Tax | ₹3.25 Cr | ₹0.17 Cr | ₹0.17 Cr |
Other taxes | ₹1.32 Cr | ₹-0.22 Cr | ₹-0.22 Cr |
Profit After Tax | ₹139 Cr | ₹168 Cr | ₹168 Cr |
Extra items | - | - | - |
Minority Interest | - | - | - |
Share of Associate | - | - | - |
Other Consolidated Items | - | - | - |
Consolidated Net Profit | ₹139 Cr | ₹168 Cr | ₹168 Cr |
Adjustments to PAT | - | - | - |
Profit Balance B/F | ₹1,104 Cr | ₹971 Cr | ₹971 Cr |
Appropriations | ₹1,243 Cr | ₹1,139 Cr | ₹1,139 Cr |
General Reserves | - | - | - |
Proposed Equity Dividend | - | - | - |
Corporate dividend tax | - | - | - |
Other Appropriation | ₹0.02 Cr | ₹12 Cr | ₹12 Cr |
Equity Dividend % | ₹40.00 | ₹40.00 | ₹40.00 |
Earnings Per Share | ₹23.70 | ₹28.56 | ₹28.56 |
Adjusted EPS | ₹23.70 | ₹28.56 | ₹28.56 |
Compare Income Statement of peers of IOL CHEMICALS AND PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IOL CHEMICALS AND PHARMACEUTICALS | ₹2,444.9 Cr | 1% | 13.2% | -14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 3.7% | 8.5% | 49.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 3.6% | 1.8% | 52.1% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 3% | 1.9% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 2.7% | 15.5% | 23.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -1.6% | 1% | 43.9% | Stock Analytics |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IOL CHEMICALS AND PHARMACEUTICALS | 1% |
13.2% |
-14.1% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses